Table 1.
Demographic and clinical parameters of the subjects enrolled in this study.
| Characteristics | Control group (N = 242) | CIN group (N = 78) | P value |
|---|---|---|---|
| Sex-no (%) | 0.8411 | ||
| Female | 169 (69.8) | 55 (70.5) | |
| Male | 73 (30.2) | 23 (29.5) | |
| Age-years | 65.6 ± 8.4 | 66.1 ± 7.9 | 0.6251 |
| Diabetes duration-years | 11.5 ± 4.8 | 12.4 ± 6.1 | 0.3169 |
| Reasons for contrast-enhanced CT-no (%) | 0.6654 | ||
| Pulmonary embolism | 48 (19.8) | 15 (19.2) | |
| Dissecting ancurysm | 20 (8.3) | 6 (7.7) | |
| Liver abscess | 98 (40.5) | 30 (38.5) | |
| Angina pectoris admitted with suspected myocardial infarction | 76 (31.4) | 43 (34.6) | |
| BMI (kg/m2)-no (%) | 0.6248 | ||
| < 18.5 (underweight) | 15 (6.2) | 7 (8.9) | |
| 18.5–24.9 (normal) | 192 (79.3) | 63 (80.7) | |
| 25.0–29.9 (overweight) | 23 (9.5) | 8 (10.4) | |
| 30.0–34.9 (class I obesity) | 12 (5.0) | 0 | |
| 35.0–39.9 (class II obesity) | 0 | 0 | |
| ≥ 40.0 (class II obesity) | 0 | 0 | |
| Hypertension-no (%) | 145 (59.9) | 45 (57.7) | 0.8221 |
| Using ACE-I/ARB-no (%) | 58/128 | 20/44 | 0.7518 |
| Dosage of contrast (ml) | 85.4 ± 7.2 | 83.8 ± 6.5 | 0.7152 |
| Using diuretics-no (%) | 114 (47.1) | 35 (44.9) | 0.3841 |
| FBG (mmol/l) | 7.9 ± 3.2 | 7.8 ± 3.6 | 0.9871 |
| HbA1c (%) | 7.3 ± 2.8 | 7.1 ± 3.4 | 0.6841 |